Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ralph M. Matar"'
Publikováno v:
American Heart Journal Plus, Vol 28, Iss , Pp 100294- (2023)
In 2021, the first rounds of modified mRNA vaccines against SARS-CoV-2 were tested and deployed. The vaccines themselves had great efficacy against severe infection, with rare and minimal side effects. One adverse effect that was reported, however, w
Externí odkaz:
https://doaj.org/article/b1c0938b32d448eaaf9a959ae349b792
Autor:
William W. King, Matthew R. Petersen, Ralph M. Matar, Jeffery B. Budweg, Lyda Cuervo Pardo, John W. Petersen
Publikováno v:
American Heart Journal Plus, Vol 8, Iss , Pp 100042- (2021)
Introduction: mRNA COVID-19 vaccines have emerged as a new form of vaccination that has proven to be highly safe and effective against COVID-19 vaccination. Rare adverse events including myocarditis have been reported in the literature. Methods: Data
Externí odkaz:
https://doaj.org/article/92e350b5337b42f89f7d048fb2547773
Autor:
Erich L. Kiehl, Alex M. Parker, Ralph M. Matar, Matthew F. Gottbrecht, Michelle C. Johansen, Mark P. Adams, Lori A. Griffiths, Steven P. Dunn, Katherine L. Bidwell, Venu Menon, Kyle B. Enfield, Lawrence W. Gimple
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 5 (2017)
BackgroundOut‐of‐hospital cardiac arrest (OHCA) results in significant morbidity and mortality, primarily from neurologic injury. Predicting neurologic outcome early post‐OHCA remains difficult in patients receiving targeted temperature managem
Externí odkaz:
https://doaj.org/article/7059318677584a678efc6712b251c713